34 related articles for article (PubMed ID: 38485151)
1. Metabolomics analysis of bronchoalveolar lavage fluid predicts unique features of the lower airway in pediatric cystic fibrosis.
O'Connor JB; Mottlowitz M; Wagner BD; Harris JK; Laguna TA
J Cyst Fibros; 2024 Jun; ():. PubMed ID: 38853065
[TBL] [Abstract][Full Text] [Related]
2. Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children.
Muhlebach MS; Zorn BT; Esther CR; Hatch JE; Murray CP; Turkovic L; Ranganathan SC; Boucher RC; Stick SM; Wolfgang MC
PLoS Pathog; 2018 Jan; 14(1):e1006798. PubMed ID: 29346420
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal dynamics of the gut microbiome and metabolome in peanut allergy development.
Chun Y; Grishin A; Rose R; Zhao W; Arditi Z; Zhang L; Wood RA; Burks AW; Jones SM; Leung DYM; Jones DR; Sampson HA; Sicherer SH; Bunyavanich S
J Allergy Clin Immunol; 2023 Dec; 152(6):1569-1580. PubMed ID: 37619819
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the upper and lower airway microbiome in early postoperative lung transplant recipients.
Li C-x; Lv M; Liu H-y; Lin Y-x; Pan J-b; You C-x; Su J
Microbiol Spectr; 2024 Jun; 12(6):e0379123. PubMed ID: 38747583
[TBL] [Abstract][Full Text] [Related]
5. Insights into the early-life chemical exposome of Nigerian infants and potential correlations with the developing gut microbiome.
Oesterle I; Ayeni KI; Ezekiel CN; Berry D; Rompel A; Warth B
Environ Int; 2024 Jun; 188():108766. PubMed ID: 38801800
[TBL] [Abstract][Full Text] [Related]
6. Upper airway microbiota development in infants with cystic fibrosis diagnosed by newborn screen.
Harris JK; Wagner BD; Robertson CE; Stevens MJ; Lingard C; Borowitz D; Leung DH; Heltshe SL; Ramsey BW; Zemanick ET
J Cyst Fibros; 2023 Jul; 22(4):644-651. PubMed ID: 37137746
[TBL] [Abstract][Full Text] [Related]
7. Microbial imbalance in Chinese children with diarrhea or constipation.
Ren J; Ren Y; Mu Y; Zhang L; Chen B; Li S; Fang Q; Zhang Z; Zhang K; Li S; Liu W; Cui Y; Li X
Sci Rep; 2024 Jun; 14(1):13516. PubMed ID: 38866797
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria.
Li C; Stražar M; Mohamed AMT; Pacheco JA; Walker RL; Lebar T; Zhao S; Lockart J; Dame A; Thurimella K; Jeanfavre S; Brown EM; Ang QY; Berdy B; Sergio D; Invernizzi R; Tinoco A; Pishchany G; Vasan RS; Balskus E; Huttenhower C; Vlamakis H; Clish C; Shaw SY; Plichta DR; Xavier RJ
Cell; 2024 Apr; 187(8):1834-1852.e19. PubMed ID: 38569543
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation.
Laguna TA; Reilly CS; Williams CB; Welchlin C; Wendt CH
Pediatr Pulmonol; 2015 Sep; 50(9):869-77. PubMed ID: 26115542
[TBL] [Abstract][Full Text] [Related]
10. Infant microbes and metabolites point to childhood neurodevelopmental disorders.
Ahrens AP; Hyötyläinen T; Petrone JR; Igelström K; George CD; Garrett TJ; Orešič M; Triplett EW; Ludvigsson J
Cell; 2024 Apr; 187(8):1853-1873.e15. PubMed ID: 38574728
[TBL] [Abstract][Full Text] [Related]
11. Bronchoalveolar Lavage Fluid Microbiota is Associated with the Diagnosis and Prognosis Evaluation of Lung Cancer.
Cheng C; Wang Z; Ding C; Liu P; Xu X; Li Y; Yan Y; Yin X; Chen B; Gu B
Phenomics; 2024 Apr; 4(2):125-137. PubMed ID: 38884058
[TBL] [Abstract][Full Text] [Related]
12. Human gut microbiota analysis of cystic fibrosis infants using metaproteomics.
García-Durán C; Saralegui C; Romeu E; Hernáez ML; Maruri A; Bastón-Paz N; Lamas A; Vicente S; Perez-Ruiz E; Delgado I; Luna-Paredes C; Caballero JD; Zamora J; Monteoliva L; Del Campo R; Gil C
Microbiol Resour Announc; 2024 Jul; ():e0005924. PubMed ID: 38967490
[TBL] [Abstract][Full Text] [Related]
13. Divergence of bacterial communities in the lower airways of CF patients in early childhood.
O'Connor JB; Mottlowitz MM; Wagner BD; Boyne KL; Stevens MJ; Robertson CE; Harris JK; Laguna TA
PLoS One; 2021; 16(10):e0257838. PubMed ID: 34613995
[TBL] [Abstract][Full Text] [Related]
14. The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis.
Frayman KB; Armstrong DS; Carzino R; Ferkol TW; Grimwood K; Storch GA; Teo SM; Wylie KM; Ranganathan SC
Thorax; 2017 Dec; 72(12):1104-1112. PubMed ID: 28280235
[TBL] [Abstract][Full Text] [Related]
15. Detection of bile acids in bronchoalveolar lavage fluid defines the inflammatory and microbial landscape of the lower airways in infants with cystic fibrosis.
Caparrós-Martín JA; Saladie M; Agudelo-Romero SP; Reen FJ; Ware RS; Sly PD; Stick SM; O'Gara F;
Microbiome; 2023 Jun; 11(1):132. PubMed ID: 37312128
[TBL] [Abstract][Full Text] [Related]
16. Microbial diversity within the airway microbiome in chronic pediatric lung diseases.
Hahn A; Warnken S; Pérez-Losada M; Freishtat RJ; Crandall KA
Infect Genet Evol; 2018 Sep; 63():316-325. PubMed ID: 29225146
[TBL] [Abstract][Full Text] [Related]
17. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Jain K; Wainwright C; Smyth AR
Cochrane Database Syst Rev; 2013 Dec; (12):CD009530. PubMed ID: 24363033
[TBL] [Abstract][Full Text] [Related]
18. The longitudinal microbial and metabolic landscape of infant cystic fibrosis: the gut-lung axis.
Frayman KB; Macowan M; Caparros-Martin J; Ranganathan SC; Marsland BJ;
Eur Respir J; 2024 May; 63(5):. PubMed ID: 38485151
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
